Showing results (51-60 of 136) with videos related to

Sort By:
Pageof 14
Nano Letters|March 27, 2009
Magnetic states in prismatic core multishell nanowiresGiulio Ferrari, Guido Goldoni, Andrea Bertoni, et al.
Journal of Ophthalmic Inflammation and Infection|September 23, 2021
Symptoms and signs of conjunctivitis as predictors of disease course in COVID-19 syndromeMartina Ranzenigo, Elena Bruzzesi, Laura Galli, et al.
BMC Ophthalmology|August 3, 2012
In vivo evaluation of DSAEK interface with scanning-laser confocal microscopyGiulio Ferrari, Verena Reichegger, Luca Ludergnani, et al.
Cornea|July 29, 2003
Analysis of limbal stem cell deficiency by corneal impression cytologyPietro Maria Donisi, Paolo Rama, Adriano Fasolo, et al.
The Ocular Surface|November 23, 2024
Biology and medicine on ocular surface restoration: Advancements and limits of limbal stem cell deficiency treatmentsVincenzo Giuseppe Genna, Eleonora Maurizi, Paolo Rama, et al.
Investigative Ophthalmology & Visual Science|March 3, 2026
The Impact of Aging and Sex on Corneal Nerve Density and FunctionGiuseppe Suanno, Philippe Fonteyne, Massimo De Micheli, et al.
Experimental Eye Research|June 18, 2013
Corneal innervation as a window to peripheral neuropathiesGiulio Ferrari, Nambi Nallasamy, Heather Downs, et al.
The Ocular Surface|April 10, 2012
Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin)William Stevenson, Sheng-Fu Cheng, Mohammad H Dastjerdi, et al.
The Ocular Surface|September 10, 2023
Topical formulations of Aprepitant are safe and effective in relieving pain and inflammation, and drive neural regenerationFilippo Bonelli, Ibrahim Demirsoy, Romina Mayra Lasagni Vitar, et al.
American Journal of Ophthalmology Case Reports|December 11, 2023
Topical fosaprepitant for the treatment of ocular pain and inflammationGiuseppe Suanno, Matteo Pederzolli, Romina Mayra Lasagni Vitar, et al.
Pageof 14